JP:4583 Stock Latest News
Company AnnouncementsChiome Bioscience Outlines Q2 FY2026 Results and R&D Focus2M ago4583
Company AnnouncementsChiome Bioscience Narrows Losses as Sales Rise and Balance Sheet Strengthens2M ago4583
Company AnnouncementsChiome Bioscience Outlines Q1 FY2026 Results and Pipeline Focus5M ago4583
Company AnnouncementsChiome Bioscience Narrows Quarterly Loss as Equity Ratio Improves, Keeps Cautious Outlook5M ago4583
Company AnnouncementsChiome Bioscience Corrects FY2025 Results as Losses and Cash Burn Persist7M ago4583
Company AnnouncementsChiome Bioscience Outlines FY2025 Results and mAb Development Focus8M ago4583Company AnnouncementsChiome Bioscience Widens Cash Burn as Sales Drop and Outlook Stays Limited8M ago4583
Company AnnouncementsChiome Bioscience’s CBA-1205: A Promising Phase I Study Update1y ago4583
Company AnnouncementsChiome Bioscience’s Innovative Phase I Study on CBA-1535: A Potential Game-Changer in Cancer Treatment1y ago4583
Company AnnouncementsChiome Bioscience Reports First Half 2025 Financial Results1y ago4583- Company AnnouncementsChiome Bioscience Reports Q1 2025 Financial Results Amid Continued Losses1y ago4583
Company AnnouncementsChiome Bioscience Updates Financial Results for FY 20241y ago4583
Company AnnouncementsChiome Bioscience Reports Modest Sales Growth Amid Continued Financial Challenges1y ago4583
Company AnnouncementsChiome Bioscience’s Tribody™ Technology Shows Promising Results in Cancer Immunotherapy1y ago4583
Company AnnouncementsChiome Bioscience’s Promising Results in CBA-1205 Phase I Study1y ago4583- Company AnnouncementsChiome Bioscience Unveils Promising Cancer Therapy Data1y ago4583
Company AnnouncementsChiome Bioscience Secures Licensing Deal with Asahi Kasei1y ago4583
Company AnnouncementsChiome Bioscience Secures Key Licensing Deal1y ago4583